文献速递急性肾损伤慢性肾脏病遗传性与小管间质肾病

白细胞介素-6促进急性和慢性肾脏病中成纤维细胞生长因子23表达增加

Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.
PubMed 文献 · Kidney Int · 2018-05-31

研究探讨白细胞介素-6(IL-6)对急性肾损伤(AKI)和慢性肾脏病(CKD)中成纤维细胞生长因子23(FGF23)升高的作用。小鼠模型显示,AKI和CKD时骨FGF23 mRNA及血清FGF23升高伴随IL-6增加;IL-6敲除CKD小鼠骨FGF23 mRNA不升高且血清FGF23升高减弱。IL-6通过sIL-6R反式信号及STAT3磷酸化直接促进FGF23转录,提示IL-6是AKI和CKD中FGF23升高的重要贡献者。

要点

  • IL-6通过sIL-6R反式信号促进骨FGF23转录。
  • IL-6敲除减轻CKD小鼠骨FGF23 mRNA和血清FGF23升高。
  • 肾脏是尿毒症状态下血清IL-6升高的来源之一。

核心结论

  • IL-6增加FGF23转录并贡献于急性和慢性肾脏病中血清FGF23的高水平。

研究设计与样本

  • 研究使用叶酸诱导AKI小鼠和腺嘌呤饮食诱导CKD小鼠,包括野生型和IL-6敲除小鼠。
  • 采用流体动力学尾注射IL-6/sIL-6R融合蛋白(HIL-6)质粒、颅盖骨器官培养和UMR106成骨样细胞实验。

主要发现

  • 叶酸诱导AKI小鼠骨FGF23 mRNA、血清FGF23及包括IL-6在内的循环细胞因子升高,地塞米松部分阻止IL-6和FGF23升高。
  • 腺嘌呤饮食CKD的IL-6敲除小鼠骨FGF23 mRNA不升高,血清FGF23升高幅度弱于野生型CKD小鼠。
  • CKD和AKI小鼠循环sIL-6R水平均升高,提示IL-6通过sIL-6R介导的反式信号增加FGF23。
  • AKI或CKD小鼠肾脏IL-6 mRNA表达增加,提示肾脏是尿毒症状态下血清IL-6升高的来源。
  • HIL-6增加颅盖骨器官培养和UMR106细胞的FGF23 mRNA,并通过STAT3磷酸化及FGF23启动子中进化保守元件增加启动子活性。

临床怎么用

  • 在AKI和CKD患者中,IL-6可能作为FGF23升高的上游驱动因素,监测IL-6通路有助于风险评估。
  • 针对IL-6/sIL-6R反式信号的干预可能成为降低FGF23水平的潜在策略。

局限性

  • 研究基于小鼠模型和细胞实验,人体临床验证尚未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The high serum fibroblast growth factor 23 (FGF23) levels in patients with acute kidney injury (AKI) and chronic kidney disease (CKD) are associated with increased morbidity and mortality. Mice with folic acid-induced AKI had an increase in bone FGF23 mRNA expression together with an increase in serum FGF23 and several circulating cytokines including interleukin-6 (IL-6). Dexamethasone partially prevented the increase in IL-6 and FGF23 in the AKI mice. IL-6 knock-out mice fed an adenine diet to induce CKD failed to increase bone FGF23 mRNA and had a muted increase in serum FGF23 levels, compared with the increases in wild-type mice with CKD. Therefore, IL-6 contributes to the increase in FGF23 observed in CKD. Hydrodynamic tail injection of IL-6/soluble IL-6 receptor (sIL-6R) fusion protein hyper IL-6 (HIL-6) plasmid increased serum FGF23 levels. Circulating sIL-6R levels were increased in both CKD and AKI mice, suggesting that IL-6 increases FGF23 through sIL-6R-mediated trans-signaling. Renal IL-6 mRNA expression was increased in mice with either AKI or CKD, suggesting the kidney is the source for the increased serum IL-6 levels in the uremic state. HIL-6 also increased FGF23 mRNA in calvaria organ cultures and osteoblast-like UMR106 cells in culture, demonstrating a direct effect of IL-6 on FGF23 expression. HIL-6 increased FGF23 promoter activity through STAT3 phosphorylation and its evolutionarily conserved element in the FGF23 promoter. Thus, IL-6 increases FGF23 transcription and contributes to the high levels of serum FGF23 in both acute and chronic kidney disease.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Durlacher-Betzer K, Hassan A, Levi R, et al. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease. Kidney Int. 2018. PMID: 29861060. doi:10.1016/j.kint.2018.02.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。